Objective: Based on our previous findings that, reflecting mild inflammation, the exposed facial skin shows much poorer functional properties of the stratum corneum (SC) in the dry and cold winter than those evaluated in the same individuals in the warm and humid summer time, we conducted a half-side test on the face to determine how the facial skin changes induced by a winter environment are improved by daily applications of a moisturizing cream as assessed by non-invasive biophysical and cytological methods. Methods: One side of the face of 16 young females was treated with a moisturizing cream twice daily for 6 weeks, with the other side serving as the non-treated control. Before treatment, 3 and 6 weeks after the start of the treatment, high-frequency conductance as a parameter of the skin surface hydration, transepidermal water loss (TEWL), a parameter of the water barrier function of the skin, and the skin surface lipid level were measured on the cheeks. Obtaining the SC from the skin surface by adhesive tape, interleukin (IL) 1α and IL-1 receptor antagonist (IL-1ra) in the SC and cornified envelope (CE) maturation were determined. Results: At first, baseline measurements conducted before treatment showed rather high TEWL values suggestive of an impaired skin barrier. During the treatment with the moisturizing cream, significantly higher conductance values and lower TEWL values were found on the moisturizer-treated side, accompanied by a decreasing IL-1ra/IL-1α ratio and immature CEs. Conclusion: These results suggested that the daily application of a moisturizing cream is effective in improving mild subclinical inflammation that is induced on the facial skin by the winter environment.

1.
Tabata N, O’Goshi K, Zhen YX, Kligman AM, Tagami H: Biophysical assessment of persistent effects of moisturizers after their daily applications: Evaluation of corneotherapy. Dermatology 2000;200:308–313.
2.
Lodén M, Andersson AC, Lindberg M: Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999;140:264–267.
3.
Lane AT, Drost SS: Effects of repeated application of emollient cream to premature neonates’ skin. Pediatrics 1993;92:415–419.
4.
Held E, Jorgensen LL: The combined use of moisturizers and occlusive gloves: An experimental study. Am J Contact Dermatitis 1999;10:146–152.
5.
Ramsing DW, Agner T: Preventive and therapeutic effects of a moisturizer: An experimental study of human skin. Acta Derm Venereol 1997;77:335–337.
6.
Ya-Xian Z, Suetake T, Tagami H: Number of cell layers of the stratum corneum in normal skin – Relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res 1999;291:555–559.
7.
Hirao T, Aoki H, Yoshida T, Sato Y, Kamoda H: Elevation of interleukin 1 receptor antagonist in the stratum corneum of sun-exposed and ultraviolet B-irradiated human skin. J Invest Dermatol 1996;106:1102–1107.
8.
Hirao T, Aoki H, Ichikawa H, Sato Y: Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet. J Dermatol Sci 1997;14:189–198.
9.
Hirao T, Denda M, Takahashi M: Identification of immature cornified envelopes in the barrier-impaired epidermis by characterization of their hydrophobicity and antigenicities of the components. Exp Dermatol 2001;10:35–44.
10.
Kikuchi K, Kobayashi H, Le Fur I, Tschachler E, Tagami H: Winter season affects more severely the facial skin than the forearm skin: Comparative biophysical studies conducted in the same Japanese females in later summer and winter. Exog Dermatol 2002;1:32–38.
11.
Tagami H, Ohi M, Iwatsuki K: Evaluation of the skin surface hydration in vivo by electrical measurement. J Invest Dermatol 1980;75:500–507.
12.
Denda M, Sato J, Tsuchiya T, Elias P, Feingold K: Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: Implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 1998;111:873–878.
13.
Terui T, Hirao T, Sato Y, Uesugi T, Honda M, Iguchi M, Matsumura N, Kudoh K, Aiba S, Tagami H: An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases. Exp Dermatol 1998;7:327–334.
14.
Hashimoto-Kumasaka K, Takahashi K, Tagami H: Electrical measurement of the water content of the stratum corneum in vivo and in vitro under various conditions: Comparison between skin surface hygrometer and corneometer in evaluation of the skin surface hydration state. Acta Derm Venereol 1993;73:335–339.
15.
Lodén M: The increase in skin hydration after application of emollients with different amounts of lipids. Acta Derm Venereol 1992;72:327–330.
16.
Mao-Qiang M, Brown BE, Wu-Pong S, Feingold KR, Elias PM: Exogenous nonphysiologic vs physiologic lipids: Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 1995;131:809–816.
17.
Serup J, Winther A, Blichmann CW: Effects of repeated application of a moisturizer. Acta Derm Venereol 1989;69:457–459.
18.
Held E, Sveinsdottir S, Agner T: Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 1999;79:49–51.
19.
Hachem JP, De Paepe K, Vanpee E, Kaufman L, Rogiers V, Roseeuw D: The effect of two moisturisers on skin barrier damage in allergic contact dermatitis. Eur J Dermatol 2002;12:136–138.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.